Report of a collaborative study to establish the first Indian Pharmacopoeia reference standard for teriparatide

A collaborative study was conducted to establish the first Indian Pharmacopoeia Reference Standard (IPRS) for teriparatide to be used in quality control testing of marketed products in compliance with the Indian Pharmacopoeia (IP) monograph. The study objective was to evaluate the candidate standard in terms of the WHO International Standard (IS) to assign its content in mg per vial terms. This study involved four laboratories from India and the candidate standard was calibrated against the WHO IS by each participant laboratory using high-performance liquid chromatography (HPLC) assay method per IP monograph. Direct calibration of the candidate standard resulted in an assigned content of 1.02 mg per vial. Based on the study results the candidate standard was judged suitable to serve as the first IPRS for teriparatide for identification and assay by HPLC. •Collaborative study to establish first Indian Pharmacopoeia Reference Standard (IPRS) for teriparatide.•Calibration of the candidate standard in terms of the WHO International Standard.•Study assigned the content of candidate standard as 1.02 mg per vial.•Candidate standard judged suitable to serve as first IPRS for teriparatide for identification and assay by HPLC.